Parsec — Register Your Interest

Own the platform
that pays physicians and providers fairly.

Parsec is a physician-built VMS and marketplace for the full spectrum of healthcare staffing — Physicians, Nurses, CRNAs, Anesthesiologist Assistants, Medical Physicists, Dosimetrists, Radiation Therapists, and Imaging & Radiology Technologists — eliminating the middlemen who take 40–60% of billable charges before pay reaches the provider. We are building toward a $2M fundraise — and we want to hear from physicians, providers, and investors who share our vision.

Staffing coverage across
Physicians Nurses CRNAs Anesthesiologist Assistants Medical Physicists Dosimetrists Radiation Therapists Radiology Technologists Nuclear Medicine & Imaging Service Line Management High-Value Consulting

Why Parsec

A rare combination: an unfair advantage,
a massive market, and the leverage to win it.

Most startups chase a market. Parsec enters one with 39 contracted health systems already waiting, a physician and provider workforce already doing the work, and a structurally broken status quo that is overdue for disruption. The opportunity is not theoretical — it is already ours to execute.

$5B+
Locum Tenens Market
Annual U.S. spend, growing 7%+ per year
$30B+
Total Addressable Market
W2 + 1099 healthcare staffing combined
39
Day-One Health System Clients
Contracted and warm — zero cold outreach needed at launch
40–60%
Agency Take from Billables
The cut physicians lose before their pay arrives — Parsec changes this
A Warm Pipeline No Competitor Can Replicate
Most platforms launch cold. Parsec launches with 39 contracted health system relationships that represent an estimated $100M+ in annual locum spend — already in our network, ready to transact on day one.
A Better Model for Everyone in the Room
The current system extracts enormous margins from both sides. Parsec's model is structurally more efficient — better for physicians, better for providers, and better for the health systems paying the bills. When every party benefits, adoption is a matter of when, not if.
Built to Disrupt a Complacent Industry
The dominant VMS platforms were not built for physicians or providers. They were built around them, to extract from them. Parsec enters from the inside — built by physicians, for every clinical specialty — which is exactly the leverage the incumbents cannot manufacture.
Provider Investors Are Also the Workforce
Investors in Parsec are not passive. As practicing locum physicians and providers — nurses, CRNAs, technologists, and more — they generate the platform's transaction volume directly. Your investment funds the platform; your work builds its revenue. No other investment in this space offers that alignment.
Multiple Revenue Streams, Active from Day One
Parsec generates revenue across several distinct streams from the moment it launches — not after years of user acquisition. All revenue streams are live on Day 1, which means the path to meaningful scale is short and already mapped.
90% of U.S. Hospitals Use Contract Staff — Most Manage It Badly
The vast majority of health systems still manage contract staffing — across all clinical specialties — through spreadsheets, phone calls, and paper contracts. The problem is acute across every service line, and the incumbents have left a wide opening for a platform that actually works.
$8M+
ARR by Year 3
ARR stands for Annual Recurring Revenue — the annualized value of predictable, repeating income the business generates. It is the primary metric investors use to measure the health and growth trajectory of a technology company.

Parsec has a clear, documented path to $8M+ ARR within three years, driven entirely by the 39 existing client relationships and the physician network already in place — before a single dollar is spent on external sales or marketing.

Total Interest Registered

$0
of $2,000,000 target
0
Registrations
0%
Funded

About This Raise

Raise Target
$2,000,000
Seed stage · pre-revenue
Stage
Seed Round
Healthcare technology platform
Individual / Physician
$25K+
Indicative minimum — subject to final terms
Institutional
$200K+
Indicative minimum — subject to final terms
Important: The figures above are indicative only and are not final terms. They do not constitute an offer to sell, or a solicitation of an offer to buy, any security. Final terms, structure, and minimums will be set in definitive offering documents prepared with legal counsel and provided only to verified accredited investors.

Which Best Describes You?

Individual · Physician
$25K+
Physician & Individual Investors
Indicative interest starting at $25,000 Open to accredited individuals & physicians Physician-investors may also participate as locums on the platform Final terms in formal offering documents only
Institutional · Group
$200K+
Institutional & Physician Groups
Indicative interest starting at $200,000 Institutional investors, funds & physician organizations Investment structure and terms in formal documents only Final terms in formal offering documents only

Register Your Interest

Tell us about yourself and your indicative level of interest. This is not a commitment — we'll be in touch with formal information when the round opens.

Interest registered — thank you.

We've logged your interest and a confirmation has been sent to your email. The Parsec team will be in touch when the round formally opens with proper offering documents.

$

Completely non-binding. Registering interest is not a commitment and not an offer or sale of securities. No money changes hands at any point through this form.

PARSEC™ · ClinicApp LLC · This page is an interest registration only and does not constitute an offer to sell, or a solicitation of an offer to buy, any security. No money changes hands through this form, and no financial commitment of any kind is created by submitting this form. Any future investment offering will be made exclusively through definitive legal documents prepared with qualified securities counsel and provided only to verified accredited investors. Past performance is not indicative of future results. Investment in early-stage companies involves substantial risk, including possible loss of principal.